Surgical and Medical Oncology Development SRL
Surgical and Medical Oncology Development reported total assets of 489,099 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Apr 2026).
By total assets for 2025, Surgical and Medical Oncology Development ranks in the top half of the 15,438 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Surgical and Medical Oncology Development shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -68 % Total assets -30 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Surgical and Medical Oncology Development's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 28,056 € | ||||
| Equity | 109,094 € | ||||
| Cash | 174,712 € | ||||
| EBITDA | 209,039 € | ||||
| Total assets | 489,099 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 03 Apr 2026
- Year ended 30 Sep 2024filed on 19 Apr 2025
- Year ended 30 Sep 2023filed on 09 Apr 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 31 Mar 2022
Surgical and Medical Oncology Development's financial analysis
- Solvency22.3%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Surgical and Medical Oncology Development
2 active director(s) in the register.
Surgical and Medical Oncology Development's shareholders and holdings →Surgical and Medical Oncology Development's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0875.441.727
- VAT number
- BE0875441727
- Peppol
- Registered · 0208:0875441727 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 05 Aug 2005
- Registered office
- 4880 Aubel
- Latest accounts
- 2025 · filed on 03 Apr 2026
- Activity
- Medical specialists activities (NACE 86220)
Surgical and Medical Oncology Development (SRL) has been based in Aubel since 2005, active in: medical specialists activities. For 2025, it reports a net profit of 28,056 € and equity of 109,094 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Surgical and Medical Oncology Development
Companies in the same business, of comparable size and area, outside its group.
- Talla Medical Medical specialists activities Walcourt · balance sheet 489,725 €
- Docteur Cornet Pierre Medical specialists activities Oupeye · balance sheet 491,444 €
- Dr. Wim Wissaert Medical specialists activities Sint-Martens-Latem · balance sheet 489,050 €
- Dr. Anssens Sarah Medical specialists activities Brakel · balance sheet 488,979 €
- Dokter Antoni De Mol Medical specialists activities Torhout · balance sheet 488,808 €
- Geros Medical specialists activities Kortrijk · balance sheet 488,753 €
- Dr. Antsje Calders Medical specialists activities Sint-Katelijne-Waver · balance sheet 489,791 €
- Profmed Medical specialists activities Neupré · balance sheet 489,906 €
Frequently asked questions about Surgical and Medical Oncology Development
What is the revenue of Surgical and Medical Oncology Development?
Surgical and Medical Oncology Development files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Surgical and Medical Oncology Development?
In Belgium, the VAT number is the company number prefixed with BE: BE0875441727 for Surgical and Medical Oncology Development, if the company is VAT-registered. Its company number (CBE) is 0875.441.727.
Where is the registered office of Surgical and Medical Oncology Development?
According to the CBE register, the registered office of Surgical and Medical Oncology Development is in 4880 Aubel.
What is the equity of Surgical and Medical Oncology Development?
At the close of the 2025 financial year, the equity of Surgical and Medical Oncology Development amounts to 109,094 €, a solvency of 22.3% of total assets.
Who manages Surgical and Medical Oncology Development?
The register lists 2 active mandates at Surgical and Medical Oncology Development. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Surgical and Medical Oncology Development within its sector?
By total assets for 2025, Surgical and Medical Oncology Development ranks in the top half of the 15,438 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Surgical and Medical Oncology Development
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →